000 | 01617 a2200409 4500 | ||
---|---|---|---|
005 | 20250511175005.0 | ||
264 | 0 | _c19930504 | |
008 | 199305s 0 0 eng d | ||
022 | _a0301-4800 | ||
024 | 7 |
_a10.3177/jnsv.38.special_353 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aClumeck, N | |
245 | 0 | 0 |
_aRecombinant granulocyte colony-stimulating factor (rG-CSF) in HIV patients with zidovudine related neutropenia. _h[electronic resource] |
260 |
_bJournal of nutritional science and vitaminology _c1992 |
||
300 |
_a353-6 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAIDS-Related Complex _xcomplications |
650 | 0 | 4 |
_aAcquired Immunodeficiency Syndrome _xcomplications |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGranulocyte Colony-Stimulating Factor _xadverse effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLeukocyte Count _xdrug effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aNeutropenia _xchemically induced |
650 | 0 | 4 |
_aPharmaceutical Vehicles _xadverse effects |
650 | 0 | 4 |
_aRecombinant Proteins _xtherapeutic use |
650 | 0 | 4 | _aSingle-Blind Method |
650 | 0 | 4 |
_aZidovudine _xadverse effects |
700 | 1 | _aWit, S D | |
700 | 1 | _aHermans, P | |
700 | 1 | _aFranchioly, P | |
700 | 1 | _aSommereijns, B | |
773 | 0 |
_tJournal of nutritional science and vitaminology _gvol. Spec No _gp. 353-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.3177/jnsv.38.special_353 _zAvailable from publisher's website |
999 |
_c1290833 _d1290833 |